AHR and neoplasm: Decades of research support the concept of DLCs serving as tumor promoters through sustained AhR activation and potential for AhR ligands to be biotransformed by CYP1A1/1A2 to carcinogens; however, the role of the AhR in biological and physiological functions is less understood [137].